Pulmonx Corp Sustainability Reports
Pulmonx Corporation is a commercial-stage medical technology company that provides minimally invasive treatments for patients with severe emphysema. Its primary offerings include the Zephyr Endobronchial Valve and the Chartis Pulmonary Assessment System.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300WZMFR0ZK7RJY40
FIGI: BBG001T4HJ52
3 reports from 2020 to 2024